ARTICLE | Company News
Biogen submits Plegridy BLA for MS
May 22, 2013 12:01 AM UTC
Biogen Idec Inc. (NASDAQ:BIIB) submitted a BLA to FDA for Plegridy peginterferon beta-1a ( BIIB017) to treat relapsing forms of multiple sclerosis (MS). The company said it expects to submit MAA to EM...